More on SNDX
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $20.56 |
|
|||
| Open | $20.19 | ||||
| 52 Wk High | $18.03 | ||||
| 52 Wk Low | $8.97 | ||||
| Day High | $20.48 | ||||
| Day Low | $19.90 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 1,205,033 | ||||
- Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Syndax Announces Participation in September Investor Conferences
- Syndax Pharmaceuticals (SNDX) PT Lowered to $33 at UBS as Revuforj New Starts Decline
- Syndax Pharmaceuticals (SNDX) PT Lowered to $40 at JPMorgan
- Form SCHEDULE 13G Syndax Pharmaceuticals Filed by: STATE STREET CORP
- Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Syndax Pharmaceuticals (SNDX) PT Lowered to $38 at H.C. Wainwright
- Syndax Pharmaceuticals (SNDX) PT Lowered to $26 at BofA Securities
- Syndax Pharmaceuticals (SNDX) Misses Q2 EPS by 7c
- Form 10-Q Syndax Pharmaceuticals For: Jun 30
Entities mentioned with SNDX
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- 13G | View Related Stories »
- PDUFA | View Related Stories »
- Show More...
